Fund Essentials

Net Assets
-
Expense Ratio
-
Dividend Yield (Current)
-
Holdings
0
Inception Date
-
Fund Family
Franklin Templeton ETF Trust
Asset Class
••••••••••
Legal Structure
••••••••••

Performance

YTD+0.03%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
NTRANatera Inc6.83%
GHGuardant Health, Inc.6.79%
KRYSKrystal Biotech Inc5.31%
INSMInsmed4.44%
UTHRUnited Therapeutics Corp4.37%
Top 10 Concentration: 45.22%
Download all 63 holdings for HELX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

HELX ETF Overview

HELX ETF (Franklin Genomic Advancements ETF) is managed by Franklin Templeton ETF Trust. sectors including Health Care, Unknown, Information Technology.

HELX performance shows a YTD return of 0.03%..

HELX top holdings include Natera Inc (6.8%), Guardant Health, Inc. (6.8%), Krystal Biotech Inc (5.3%), Insmed (4.4%), United Therapeutics Corp (4.4%). View all HELX holdings, sector breakdown, or dividend history.

HELX can be compared against other funds using the overlap calculator or side-by-side comparison tool. HELX alternatives are available via the screener, along with tax-loss harvesting opportunities.

1 Month
+12.18%
YTD
+0.03%
1 Year
+37.52%
3 Year
+6.45%

Top 10 Holdings (45.2% of portfolio)

#TickerNameSectorWeight
1NTRANatera IncHealth Care6.83%
2GHGuardant Health, Inc.Health Care6.79%
3KRYSKrystal Biotech IncHealth Care5.31%
4INSMInsmedHealth Care4.44%
5UTHRUnited Therapeutics CorpHealth Care4.37%
6BBIOBridgebio Pharma IncHealth Care4.11%
7LGNDLigand Pharmaceuticals IncHealth Care3.49%
8AZN:LNAstrazeneca PlcUnknown3.46%
9ADPTAdaptive Biotechnologies CorpHealth Care3.29%
10207940:KRSamsung Biologics Co LtdUnknown3.13%